Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

HYDROMOX R

QUINETHAZONE; RESERPINE

Standard Dose
50MG;0.125MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview HYDROMOX R is listed in Drugs@FDA under application 013927 (NDA).

Marketing status: Discontinued Active ingredient QUINETHAZONE; RESERPINE Form and strength TABLET;ORAL - 50MG;0.125MG Sponsor LEDERLE Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview HYDROMOX R is listed in Drugs@FDA under application 013927 (NDA). Marketing status: Discontinued Active ingredient QUINETHAZONE; RESERPINE Form and strength TABLET;ORAL - 50MG;0.125MG Sponsor LEDERLE Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.